Keytruda LoE: Does it end or exacerbate the combination pricing problem?
Achieving price solutions for combination regimens that are mutually acceptable to both industry and payers in global healthcare systems, is a challenge that...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Mr. Aaron Everitt is a principal in the Life Sciences Practice of CRA. He has over five years of consulting experience in Pricing & Market Access, across the EU and US, with experience in LATAM, APAC and MEA. Dr. Everitt has a PhD background in immunology and virology.